Metabolic

Global Comprehensive Metabolic Panel Testing Market to 2027

DUBLIN, March 23, 2022 /PRNewswire/ — The “Comprehensive Metabolic Panel Testing Market Research Report by Disease, by Test Type, by Test Type, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets .com’s offering.

The Global Comprehensive Metabolic Panel Testing Market size was estimated at USD 6,914.84 million in 2020, is expected to reach USD 7,614.67 million in 2021, and is projected to grow at a CAGR of 10.48% to reach USD 13,898.02 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies – USD, EUR, GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Comprehensive Metabolic Panel Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Disease, the market was studied across Diabetes, Kidney Disease, Liver Disease, and Others.
  • Based on Test Type, the market was studied across Electrolytes, Glucose, Kidney Tests, Liver Functional Tests, and Proteins.
  • Based on Test Type, the market was studied across Electrolytes, Glucose, Kidney Tests, Liver Functional Tests, and Proteins.
  • Based on End User, the market was studied across Laboratory and PoC.
  • Based on Region, the market was studied across the Americas, Asia Pacificand Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexicoand United States. The United States is further studied across California, Florida, Illinois, new York, Ohio, Pennsylvaniaand Texas. the Asia Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, south korea, Taiwanand Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emiratesand United Kingdom.

Competitive Strategic Window:
The Competitive Strategic Window analyzes the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Comprehensive Metabolic Panel Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of ​​its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of ​​the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Comprehensive Metabolic Panel Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Comprehensive Metabolic Panel Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Comprehensive Metabolic Panel Testing Market?
4. What is the competitive strategic window for opportunities in the Global Comprehensive Metabolic Panel Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Comprehensive Metabolic Panel Testing Market?
6. What is the market share of the leading vendors in the Global Comprehensive Metabolic Panel Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Comprehensive Metabolic Panel Testing Market?

Key topics covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. drivers
5.1.1.1. Growing incidence of chronic diseases globally
5.1.1.2. Potential need for early diagnosis and treatment among the population
5.1.1.3. Rising elderly population coupled with increase in biopsy processes
5.1.2. restraints
5.1.2.1. Probability of false results on testing
5.1.3. opportunities
5.1.3.1. Emerging introduction of innovative solutions to improve efficiency and reduce errors
5.1.3.2. Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
5.1.4. challenge
5.1.4.1. Changing regulatory system creating ambiguity among manufacturers
5.2. Cumulative Impact of COVID-19

6. Comprehensive Metabolic Panel Testing Market, by Disease
6.1. Introduction
6.2. diabetes
6.3. Kidney Disease
6.4. Liver Disease
6.5. Others

7. Comprehensive Metabolic Panel Testing Market, by Test Type
7.1. Introduction
7.2. electrolytes
7.3. glucose
7.4. kidney tests
7.5. Liver Functional Tests
7.6. proteins

8. Comprehensive Metabolic Panel Testing Market, by Test Type
8.1. Introduction
8.2. electrolytes
8.3. glucose
8.4. kidney tests
8.5. Liver Functional Tests
8.6. proteins

9. Comprehensive Metabolic Panel Testing Market, by End User
9.1. Introduction
9.2. Lab
9.3. PoC

10. Americas Comprehensive Metabolic Panel Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Comprehensive Metabolic Panel Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. south korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Comprehensive Metabolic Panel Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. quadrants
13.1.2. Business Strategies
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market share analysis, by key players
13.4. competitive scenario
13.4.1. Mergers & Acquisitions
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investing & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profile
14.1. Abaxis, Inc
14.2. Abbott Laboratories
14.3. Associated Regional and University Pathologists, Inc.
14.4. Baptist Health
14.5. Bioscientia Institute for Medical Diagnostics GmbH
14.6. CENTOGENE NV
14.7. Charles River Laboratories, Inc.
14.8. Cleveland HeartLab, Inc
14.9. Genoptix, Inc.
14.10. Laboratory Corporation of America Holdings
14.11. NeoGenomics Laboratories, Inc.
14.12. OPKO Health, Inc.
14.13. Quest Diagnostics Incorporated
14.14. Scion Lab Services, LLC
14.15 Siemens Healthineers AG
14.16. Sonic Healthcare Limited
14.17. SYNLAB International GmbH
14.18. TCG Corp
14.19. The Care Group
14.20 Walk-In Lab, LLC

15. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/c05wsg

Media contact:

Research and Markets
Laura WoodSenior Manager
[email protected]

For EST Office Hours Call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside US): +353-1-481-1716

SOURCE Research and Markets

Related Articles